Covaxin receives GMP certificate from Authorities of Hungary

Bharat Biotech intends to submit documentation for Emergency Use Authorisation (EUA) in several additional countries worldwide

103

Last Updated on August 7, 2021 by The Health Master

Covaxin has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities, Bharat Biotech said in a statement.

The approval received is from the National Institute of Pharmacy and Nutrition Hungary certifying the GMP for the manufacturing of Covaxin.

The certificate of GMP is now listed on the EudraGMDP database, which is the database of the European Community of manufacturing authorisations and certificates of the good manufacturing practice.

Bharat Biotech intends to submit documentation for Emergency Use Authorisation (EUA) in several additional countries worldwide, it added.

Zydus Cadila gets final nod from USFDA for Fulvestrant injection

USFDA inspection ends with ‘Zero’ observations: Alkem

Granules Pharma clears USFDA audit

Zydus Cadila gets USFDA nod for Ibrutinib tablets

Lupin gets USFDA nod for generic Antifungal drug

Unichem gets tentative USFDA nod for drug to treat Diabetes

7 Tips Every Men Should Follow In Healthy Skincare Regime

Only 0.20% of drug samples declared Adulterated in FY 2020-21

Govt to amend New Drugs and Clinical Trials Rules 2019

CDSCO approves 12 laboratories for BA/BE studies

FAQs on Medical Devices Rules, 2017

FAQs on New Drug, Banned drugs etc.

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner